I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

about

Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.

P2860

Q48747768-41430C8F-7BA1-4D66-94EF-3E0E9CEE02F6

P2860

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

Item

http://www.wikidata.org/entity/Q38635697

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

@en

type

Item

label

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

@en

prefLabel

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

@en

P1476

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model

@en

P2093

Ali El-Armouche

http://www.w3.org/2001/XMLSchema#string

Birgit Geertz

http://www.w3.org/2001/XMLSchema#string

Frederik Flenner

http://www.w3.org/2001/XMLSchema#string

Hannieh Sotoud

http://www.w3.org/2001/XMLSchema#string

Lucie Carrier

http://www.w3.org/2001/XMLSchema#string

Silke Reischmann

http://www.w3.org/2001/XMLSchema#string

Silvio Weber

http://www.w3.org/2001/XMLSchema#string

Thomas Eschenhagen

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes

Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes

Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy

Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice

Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice

Physiologic importance of protein phosphatase inhibitors

P304

87-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJCHA.2015.05.010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Felix W Friedrich

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277478459

http://www.w3.org/2001/XMLSchema#string

P698

28785686

http://www.w3.org/2001/XMLSchema#string

P859

Collaborative Research Centre (CRC) 1002: "Modulatory Units in Heart Failure"

P932

5497269

http://www.w3.org/2001/XMLSchema#string

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

about

P2860

P2860

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P859

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P859

P932